Coronavirus drives sales of hi-tech mobile x-ray units
The Adelaide-based company reported to the Australian Securities Exchange that sales of its flagship lightweight mobile x-ray machine had reached $1.8 million for the quarter with $1 million worth of sales in the past 20 days. With two weeks of the March quarter remaining, the result has already dwarfed December quarter DRX Revolution Nano sales of $384,000 and is almost on par with the $1.9 million in sales achieved in the entire 2019 financial year. There is a requirement for urgent delivery of the latest batch of orders within a four-week time frame. These additional purchase orders are for delivery to Asia and Europe. The company said while the orders through its distributor Carestream Health did not specify the end customer, it was understood that due to the size and urgency of the orders, some of these Nano units were to be deployed in connection with the ongoing COVID-19 coronavirus outbreak. While the standard lead time for the delivery of a Nano is between 8-12 weeks from order date, Micro-X says it has been able to deliver its recent February orders within a time frame of approximately four weeks from order date. Early-stage diagnosis of coronavirus is by a blood test to confirm the infectious agent, and a chest x-ray is used as an essential part of diagnosis of the development and progression of the severity of the illness. Like with pneumonia, a chest x-ray is used to detect fluid in the lungs, particularly with patients presenting with severe acute respiratory distress. Micro-X managing director Peter Rowland said the mobile x-ray imaging units offered a flexibility of use most suited to the requirements of infection control procedures and also the nature of temporary hospital quarantine buildings. “With the alarming state of this growing epidemic, we are pleased that our Nano […]